HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Inganäs, M. Articles by Tooke, N. Search for Related Content PubMed PubMed Citation Articles by Inganäs, M. Articles by Tooke, N. Related Collections Molecular Diagnostics and Genetics

Enzymatic Mutation Detection in the P53 Gene

¹ Amersham Pharmacia Biotech, SE-751 84 Uppsala, Sweden.

² Department of Surgery, Uddevalla Hospital, SE-541 80 Uddevalla, Sweden.

³ Department of Surgery, University Hospital of Northern Sweden, SE-901 85 Umeå, Sweden.
^a Author for correspondence. Fax 46-18-6121826; e-mail sara.byding{at}eu.apbiotech.com

Background: The enzymatic mutation detection (EMD) assay uses the bacteriophage resolvase T4 endonuclease VII, which cleaves preformed heteroduplex molecules at mismatch sites, forming two shorter fragments that can be resolved by gel electrophoresis. The method can be used to detect single and multiple base changes, as well as insertions and deletions.

Methods: The sensitivity, specificity, and positional accuracy of mutation detection by EMD with the PASSPORT^TM Mutation Scanning Kit were assessed in a blind fashion for three analytical platforms (radioactive detection and automated laser sequencers ALFexpress and ABI PRISM 377). PCR products of 703 bp covering codons 188–393 of the P53 gene were prepared from colorectal tumor samples and analyzed by EMD; the results were compared to data from cDNA sequencing. A 1362-bp PCR product prepared from IL4r gene was used to test detection of multiple base changes in long PCR products.

Results: The sensitivity for detection of mutations using EMD exceeded 90%, and the specificity exceeded 80% on all analysis platforms. The method localized 90% of mutations to within two codons and four codons for automated laser sequencers and detection by radioactivity, respectively. The method detected at least five mismatches in heteroduplexes >1 kb.

Conclusions: The EMD system facilitates efficient detection of genetic variation in fragments exceeding 1 kb irrespective of location and type. The technology is particularly well suited to the detection of mutations in genes frequently mutated at unpredictable locations.

The following articles in journals at HighWire Press have cited this article:

				T. Norberg, S. Klaar, L. Lindqvist, T. Lindahl, J. Ahlgren, and J. Bergh Enzymatic Mutation Detection Method Evaluated for Detection of p53 Mutations in cDNA from Breast Cancers Clin. Chem., May 1, 2001; 47(5): 821 - 828. [Abstract] [Full Text] [PDF]

				E. P. Diamandis Sequencing with Microarray Technology--A Powerful New Tool For Molecular Diagnostics Clin. Chem., October 1, 2000; 46(10): 1523 - 1525. [Full Text] [PDF]